| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $619.8M | — | -10.5% |
| R&D Expense | $44.9M | — | -15.6% |
| SG&A Expense | $199.3M | — | +6.6% |
| Operating Income | -$31.8M | — | -197.5% |
| Pre-tax Income | -$79.5M | — | -803.4% |
| Income Tax | $12.3M | — | +215.4% |
| Net Income | -$91.8M | — | -622.8% |
| EPS (Basic) | -$1.35 | — | -610.5% |
| EPS (Diluted) | -$1.35 | — | -610.5% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $140.4M | -17.3% | +10.5% |
| Accounts Receivable | $359.9M | -13.7% | +25.8% |
| Inventory | $611.5M | +5.9% | +8.6% |
| Current Assets | $1.38B | -4.9% | +9.4% |
| Total Assets | $5.63B | -2.4% | -12.9% |
| Current Liabilities | $962.4M |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.0M | — | -150.3% |
| Capital Expenditures | $34.0M | — | -39.5% |
| Investing Cash Flow | -$34.0M | — | +39.5% |
| Financing Cash Flow | $37.6M | — | +113.6% |
| Free Cash Flow | -$67.0M | — | -812.8% |
| -8.1% |
| Long-term Debt | $2.46B | -8.8% | +16.8% |
| Total Liabilities | $3.78B | -1.9% | +9.0% |
| Stockholders' Equity | $1.85B | -3.6% | -38.2% |